Guardant Health (NASDAQ:GH – Get Free Report) had its price objective dropped by research analysts at Canaccord Genuity Group from $45.00 to $30.00 in a research report issued to clients and investors on Monday, Benzinga reports. The firm currently has a “buy” rating on the stock. Canaccord Genuity Group’s target price indicates a potential upside […]
Guardant Health (NASDAQ:GH – Get Free Report)‘s stock had its “neutral” rating reiterated by investment analysts at Guggenheim in a research report issued on Friday, Benzinga reports. Several other equities research analysts have also recently issued reports on the stock. Wolfe Research initiated coverage on shares of Guardant Health in a research report on Wednesday, […]
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twelve analysts that are currently covering the company, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating and ten have issued a buy rating on the company. The average […]
Qsemble Capital Management LP acquired a new stake in Guardant Health, Inc. (NASDAQ:GH – Free Report) during the third quarter, according to its most recent filing with the SEC. The firm acquired 11,505 shares of the company’s stock, valued at approximately $341,000. A number of other hedge funds have also recently bought and sold shares […]
Shares of Guardant Health, Inc. (NASDAQ:GH – Get Free Report) have received a consensus recommendation of “Buy” from the fourteen ratings firms that are currently covering the stock, Marketbeat Ratings reports. Fourteen research analysts have rated the stock with a buy rating. The average 1-year price objective among brokerages that have covered the stock in […]